Murphy & Mullick Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$461K Buy
1,741
+11
+0.6% +$2.9K 0.28% 76
2026
Q2
$439K Buy
1,730
+102
+6% +$23.8K 0.27% 83
2026
Q1
$398K Hold
1,628
– – 0.29% 81
2025
Q4
$337K Buy
1,628
+6
+0.4% +$1.19K 0.24% 93
2025
Q3
$302K Sell
1,622
-8
-0.5% -$1.37K 0.22% 102
2025
Q2
$266K Buy
1,630
+85
+6% +$13.1K 0.22% 103
2025
Q1
$256K Sell
1,545
-3
-0.2% -$469 0.25% 95
2024
Q4
$224K Buy
+1,548
New +$240K 0.21% 106

Other funds holding JNJ

Murphy & Mullick Capital Management's JNJ Position: Q3 2026 in Review

Murphy & Mullick Capital Management increased its Johnson & Johnson (JNJ) stake by 0.64% in Q3 2026, buying an estimated $2.9K and bringing the position to 1,741 shares worth $461K. The position accounts for 0.28% of the portfolio, ranked #76.

Murphy & Mullick Capital Management first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Murphy & Mullick Capital Management held 1,741 shares of Johnson & Johnson worth $461K as of Q3 2026.
  • Murphy & Mullick Capital Management bought 11 Johnson & Johnson shares in Q3 2026, an estimated $2.9K.
  • Johnson & Johnson made up 0.28% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #76 holding.
  • Murphy & Mullick Capital Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.